Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Technology Enables Fast Plasma Collection from Small Blood Samples

By LabMedica International staff writers
Posted on 05 May 2014
A "lab-on-a-card" collection technology now enables rapid generation of plasma from a single finger-prick blood sample, at high quality suitable for applications such as LC-MS/MS analysis.

Shimadzu Scientific Instruments (SSI; Columbia, MD, USA), subsidiary of Shimadzu Corporation (Kyoto, Japan), has introduced Noviplex Cards, a next-generation sample collection tool for accelerated blood plasma collection and analysis. More...
The cards allow for rapid collection of a volumetric sample of plasma from an unmeasured small amount of whole blood within minutes. They are ideal for uses such as LC-MS/MS analysis. Noviplex also provides exceptional reproducibility independent of hematocrit, 99% removal of red blood cells, and rapid sample preparation for MS-based analysis while maintaining assay reproducibility and selectivity.

Noviplex Cards simplify blood collection by eliminating the need for phlebotomy, syringes, and glass collection tubes. Plasma can be generated from specimen volumes ranging from 20–75 µL of whole blood. The technology offers a single-step, solid-phase method for sample preparation and analyte extraction. It accelerates processes by eliminating refrigeration, centrifugation, solvent extraction, and evaporation.

Shimadzu partnered with Novilytic Laboratories (Novilytic; North Webster, IN, USA) to offer the Noviplex Cards. “Next-generation Novilytic Laboratory advances in sample collection and preparation vastly accelerate disease marker analysis and enable a paradigm change in clinical chemistry, wellness monitoring, and medicine,” said Fred Regnier, PhD, professor emeritus, John H. Law distinguished professor of Chemistry, Purdue University, and a co-founder of Novilytic. “Noviplex technology enables lab-free sample preparation, and the convenient ‘lab-on-a-card’ format rapidly generates plasma for LC-MS/MS analysis,” said Scott Kuzdzal, PhD, life science business unit manager at SSI; “This will greatly simplify collection and processing in medical clinics, labs, and hospitals.”

Related Links:

Shimadzu Scientific Instruments
Noviplex Cards
Novilytic Laboratories



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
Multi-Chamber Washer-Disinfector
WD 390
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.